Freelance MD, a community of physicians that gives you more control of your career, income, and lifestyle. Join us. It's free, which is a terrific price. Grab Some Free Deals
Search Freelance MD

Freelance MD RSS    Freelance MD Twitter     Freelance MD Facebook       Freelance MD Group on LinkedIn      Email

Sponsors

2nd MD Special Offer

ExpedMed CME
Medical Fusion Conference

Medvoy Society of Physician Entrepreneurs

20 Newest Comments
Newest Nonclinical Physician Jobs
Thoughtstream
This area does not yet contain any content.
Navigation
« Love & Work | Main | Where Have All the BioAngels Gone? »
Friday
Dec102010

Biotech Deals in 2011

PIPES, option licensing and reverse mergers are starting to look pretty again.

It's difficult to read the tea leaves when it comes to 2011 Biotech and Life Science financing trends, according to the Life Sciences Group at www.headwatersmb.com

An analysis determined mixed messages regarding financing, M&A and partnering opportunities in the broad healthcare markets going into 2011.  

While an IPO window opened during the first quarter of 2010, that window has closed for the foreseeable future. However, there has been a recent uptick in follow-on and PIPE (private investment in public equity) offerings over the last couple of months.  

Although venture investment in life sciences was less in 3Q2010 than the previous quarter, VC investment in the sector in 2010 is on pace to exceed the total amount invested in 2009. Nonetheless, the VC markets remain tight. Many companies are seeking alternative or supplemental sources of capital such as the 2,923 life science companies that recently received grants under the new Qualifying Therapeutic Discovery Project (created by the Affordable Care Act).  

Other mixed messages in 2010: Partnering transaction volume is down, but mean transaction size is up. M&A activity is up, but mean transaction size is down.  

It is a unique transaction environment for life science companies. We believe both the private and IPO markets will remain tight but follow-on and PIPE activity might pick up. We also believe M&A and partnering activity stay consistent or pick up slightly.

Here's a link to the Life Sciences Partnering Commentary.

Reader Comments

There are no comments for this journal entry. To create a new comment, use the form below.

PostPost a New Comment

Enter your information below to add a new comment.

My response is on my own website »
Author Email (optional):
Author URL (optional):
Post:
 
All HTML will be escaped. Hyperlinks will be created for URLs automatically.

Join Freelance MD

captcha
Freelance MD is an active community of doctors.

All rights reserved.

LEGAL NOTICE & TERMS OF SERVICE